Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The Company manufactures and markets pharmaceuticals formulations as branded generics, as well as generics in India, the United States (US) and several other markets across the world.
The Company’s business is divided into four segments: Indian Branded Generics, US Generics, International Branded Generics (ROW) and Active Pharmaceutical Ingredients (API).
Its brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. It makes specialty APIs, including peptides, steroids, hormones and anticancers. APIs and Dosage forms are made at 20 plants across India, Israel, the US, Canada, Hungary, Brazil, Mexico and Bangladesh. Its API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol.
In September 2010, it acquired Taro Pharmaceutical industries Ltd.
Sun Pharma: Leveraging its generic market capabilities
|2010||Acquired controlling stake in Israel-based Taro Pharmaceuticals, effectively doubling the company’s US business.|
|2000||Became the fifth largest Indian pharmaceutical company|
|1995||First API manufacturing plant was built in Panoli, Gujarat|
|1991||Established its first research centre|
|1983||Commenced operations in Kolkata|
Updated: December, 2014